Fig 1 Redhead modification ofthe Littlepneumatic prosthesis
is given to overcoming contracture, and to strengthening the contralateral limb although the more active exercises are reserved until removal of sutures at about three weeks.
It is desirable to achieve ambulation as early as possible, not only to boost morale, but also to maintain and stimulate normal postural reactions and balance (Davis 1973) . This was accomplished here, seven days postoperatively by using the pneumatic prosthesis (Fig 1) modified at the Limb Fitting Centre, Queen Mary's Hospital, Roehampton by Dr R Redhead from a design by Little (Little 1971) . This consists of a double outer plastic cylinder which extends from the groin to a point distal to the end of the stump, and a smaller inner plastic bag which is invaginated on itself to contain the end of the stump. Both these are inflated to a pressure of 40 mmHg, and an adjustable metal frame with rocker base is attached by encircling webbing straps. This prosthesis may be applied over dressings. Subsequently, the patient graduates to the temporary ischial bearing pylon, and is taught the basic essentials of a good gait pattern, such as stability in stance on the prosthesis, equal size steps, smooth weight transference and avoidance of circumduction, together with adaptation to walking on an artificial limb and getting used to taking weight on the socket. When the stump has adequately matured, rehabilitation continues along these lines with the definitive PTB prosthesis. After three months of carbimazole therapy, partial thyroidectomy was carried out. Three days postoperatively she complained of facial paresthesix and the next day Chvostek's and Trousseau's signs became positive. The serum calcium was 7.3 mg/100 ml. Treatment was given, in the form of calcium gluconate and calciferol by mouth, with gradual disappearance of symptoms, and return of the serum calcium to normal. By the time of discharge, she was stabilized on calciferol 1.25 mg twice daily (100 000 units daily) and dihydrotachysterol 1 ml daily. She was also placed on L-thyroxine 0.1 mg twice daily. For the next fifteen years she remained well, Three months later (in June 1973), she complained of nausea, giddiness, headaches, consti-* pation and polyuria. She looked unwell, but no * specific abnormality was found on examination. She was admitted forthwith for investigation. paresthesixv, this time in the hands. The serum calcium a month before had been in the normal range (9.9 mg/100 ml) and it was thought she might now be frankly hypocalcEemic. Blood was taken for serum calcium, and meanwhile her calciferol was increased from 2 tablets daily (100 000 units) to 3 tablets daily (150 000 units).
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At her next visit, five weeks later, it was found that her serum calcium had been 11.7 mg/100 ml, somewhat surprising in view of her symptoms. The calciferol was therefore reduced to its former dosage of 100 000 units daily.
Treatment andProgress (see Fig 2) Calciferol was stopped on admission, and the serum calcium slowly fell, over about a month, to 12.5 mg/100 ml. At that point for reasons unexplained (? bed rest), it started to rise again, and reached 14.6 mg/100 ml, higher than whilst taking calciferol. A three-week course of prednisolone, starting with 60 mg daily and reducing to zero, resulted in a fall of serum calcium from 14.6 to 9.3 mg/100 ml, with a correspondingly dramatic improvement in the patient's clinical state.
By the end of another fortnight, her serum calcium had again risen to 13.2 mg/100 ml. A further course of prednisolone was then given, this time for a week only; the serum calcium again fell, to 11.0 mg/100 ml. Thereafter, on neither calciferol nor prednisolone, there has been a slow downward trend of the serum calcium toward normal (Fig 2) . Our most recent value, on 1.3.74, is 9.9 mg/100 ml. All this time, the patient's clinical state paralleled the serum calcium level. Above 11 mg/ 100 ml, she experienced nausea, malaise and polyuria; when normocalcemic, she felt perfectly well.
Discussion
The main point of interest is the continuing hypercalcmemia after discontinuation of calciferol. Several differential diagnostic possibilities emerge.
(1) That the biological half-life of exogenous calciferol (vitamin Ds) is exceedingly longperhaps a year or more (Dent 1966) . In this case the additional tablet of calciferol was given for a period of only five weeks.
(2) That this patient is unusually sensitive to the effects of calciferol. This does not seem likely, in view of the 15 normocalcmemic years whilst on two tablets a day. More indirectly, her renal impairment would if anything have made her less, not more, sensitive to vitamin D, as the final stage in its activation (to 1.25 dihydroxycholecalciferol) occurs in the kidney (Kodicek 1974) . Renal failure is one cause of vitamin Dresistant rickets.
(3) That the patient inadvertently changed brands ,of calciferol tablets. Dent (1972) has observed that considerable variations between different brands may occur, thereby giving the patient an unsuspected change in dosage. However, both the Whittington Hospital pharmacy and the patient's own chemist dispense the same brand, and neither had changed brands recently (Wiseman 1972). (4) Deliberate or accidental overdose by the patient. This was not thought likely, as she was careful and cooperative about her treatment and denied mistakes. (5) Factitious hypoparathyroidism. Transient hypocalcemia, due to parathyroid bruising, is well recognized postoperatively. Had this been the case here, there would have been no need for long-term therapy with calciferol. Indeed, such therapy would almost certainly have induced hypercalcemia early on, in the dosage used in this patient. Furthermore, several calcium levels over the years have been subnormal (Fig 1) , which mediates against normal parathyroid function. (6) Hypercalccmia for some entirely unconnected reasons, e.g.: malignancy, sarcoidosis, myeloma or hyperparathyroidism. Of these, the first three did not appear likely on clinical grounds, and a wide range of investigations was negative. Hyperparathyroidism, whilst not excluded, was made rather unlikely by the striking response to corticosteroids, and by the continuing spontaneous fall in serum calcium.
The confirmatory evidence came in the form of three grossly elevated serum cholecalciferol levels, taken at least two months after stopping calciferol. These levels indicated that the drug was still present in the body, and that the correct interpretation of this problem was the first mentioned abovenamely, that exogenous calciferol possesses an exceedingly long half-life in vivo.
Conclusion and Alternative Treatment
Our case is therefore a dramatic illustration of the longevity of action of exogenous calciferol, and a caveat, if one were needed, in the use of this drug. It is worth remembering that the related drug, dihydrotachysterol, has comparable antirachitic activity, but a much shorter biological half-life. It is, however, rather expensive, and shares the disadvantage of being relatively inactive when renal impairment is present. A recent advance in this direction has been the use of compounds, such as 1-alpha-hydroxycholecalciferol, which do not require activation in the kidney (Chalmers et al. 1973 ).
Dr L J Findlay asked if they were sure that the patient had not been taking any other drugs during this time, such as hypnotics or sedatives. Dr Morrison replied that the patient had not taken any other medication.
Dr V W Johnson said that most postthyroidectomy hypocalcaemias were transient and probably due to cedema or temporary impairment of blood supply. In this case the presence of an ultimately normal calcium level (without treatment) in a patient who is apparently clinically normal suggests that there may well be some normally functioning parathyroid tissue present.
(meeting to be continued)
